Filing Details
- Accession Number:
- 0001737287-25-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-05 16:16:37
- Reporting Period:
- 2025-02-03
- Filing Date:
- 2025-02-05
- Accepted Time:
- 2025-02-05 16:16:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1737287 | Allogene Therapeutics Inc. | ALLO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1362155 | Martin Earl Douglas | 210 East Grand Ave South San Francisco CA 94080 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-03 | 6,404 | $1.71 | 587,848 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's electionunder its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Billionaire Hedge Funds
